Social Determinants of Health Affect Monitoring for Diabetic Retinopathy

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 16, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 16, 2024 -- Certain social determinants of health (SDOH) affect monitoring for diabetic retinopathy (DR), according to a study published online Sept. 12 in JAMA Ophthalmology.

Azraa S. Chaudhury, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined the association between multiple SDOH and monitoring for DR in accordance with clinical practice guidelines (CPGs) in a cohort study conducted in 11 U.S. medical centers including 37,397 adults with diabetes.

The researchers found that the odds of having eye-care visits were lower for Black and White patients with diabetes living in rural communities compared with those of the same race in urban communities (adjusted odds ratios [aORs], 0.12 and 0.75, respectively). Higher odds of having an eye-care visit were seen for sicker Black and White patients, defined by the Charlson Comorbidity Index (aORs, 1.04 and 1.05, respectively). Black patients with preexisting DR had lower odds of visits, while White patients with preexisting DR had higher odds of visits compared with those without preexisting DR. Lower odds of eye-care visits were reported by White patients with Medicare and Medicaid compared with those with commercial health insurance. Lower odds of eye-care visits were also reported by Hispanic White patients versus non-Hispanic White patients (aOR, 0.85).

"This study found that approximately half of patients with diabetes were undergoing DR monitoring that conformed to CPGs," the authors write. "These findings support exploring targeted interventions to improve care quality for these groups."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-09-17 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords